Martin Schultz

Martin Schultz serves as a Clinical Associate Professor in the Department of Clinical Medicine under the Faculty of Health and Medical Sciences at the University of Copenhagen. His clinical appointment is based at Gentofte Hospital (Gentofte Hospitalsvej 1, 2900 Hellerup) with additional affiliation to the Blegdamsvej campus (2200 København N), specializing in Internal Medicine: Geriatrics. His research integrates clinical practice with academic investigation in elderly care.

Dr. Schultz's research focuses on critical geriatric syndromes including frailty, sarcopenia, and acute care biomarkers. His work examines falls risk, physical decline during cancer treatment, and novel diagnostic markers like GDF-15 and neutrophil gelatinase-associated lipocalin. Recent publications demonstrate strong emphasis on cross-sectional analyses of acutely admitted elderly patients and validation of clinical prediction models.

His publication record shows significant collaboration across Danish medical institutions, particularly through the Copenhagen PROTECT Study and BIOFRAIL research. The 2025 policy commentary co-authored with 25 researchers highlights his active role in shaping national geriatric research strategy. Current work includes machine learning applications for mortality prediction using routine blood tests and investigation of partial oral antibiotic therapy in endocarditis.

Scientific contributions include:

• Development of frailty-sarcopenia diagnostic frameworks
• Validation of biomarkers for acute kidney injury
• Analysis of physical decline in oncogeriatric populations
• Machine learning models for acute care mortality prediction

Dr. Schultz maintains active clinical research through hospital-based studies at Copenhagen University Hospital facilities, with recent work emphasizing translational applications of geriatric assessment tools. His collaborations span cardiology, oncology, and nephrology departments, reflecting interdisciplinary approaches to elderly care challenges.